Skip to main navigation Skip to search Skip to main content

Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K

  • Natasha Kruglyak
  • , David E. Williams
  • , Henry Chen
  • , Simon Law
  • , Jadwiga Kaleta
  • , Ivan Villanueva
  • , Julian E. Davies
  • , Raymond J. Andersen
  • , Dieter Brömme

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Using a human cathepsin K-targeting inhibitor screen, a new leupeptin analogue, leupeptazin (1), containing an unprecedented piperidinotriazine moiety, was isolated from a liquid culture of soil Streptomyces sp. IS2-4 collected in northern Italy. The structure of leupeptazin was established using HRESIMS as well as 1D and 2D NMR data. The inhibitory activity of the compound towards the collagenase cathepsin K was tested in vitro to reveal moderate activity with an inhibition constant, Ki, of 44 μM.

Original languageEnglish
Pages (from-to)1397-1400
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number6
DOIs
StatePublished - 2017
Externally publishedYes

Keywords

  • Leupeptin
  • Protease inhibition
  • Streptomyces
  • Structure elucidation

Fingerprint

Dive into the research topics of 'Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K'. Together they form a unique fingerprint.

Cite this